Trusopt



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Glaucoma 46.2%
Intraocular Pressure Increased 12.3%
Open Angle Glaucoma 8.7%
Hypertension 4.8%
Normal Tension Glaucoma 4.8%
Ocular Hypertension 3.6%
Venous Occlusion 2.7%
Infection Prophylaxis 2.1%
Anterior Chamber Disorder 1.8%
Cataract Operation 1.5%
Corneal Epithelium Disorder 1.2%
Developmental Glaucoma 1.2%
Diabetes Mellitus 1.2%
Ill-defined Disorder 1.2%
Inflammation 1.2%
Intraocular Pressure Test 1.2%
Postoperative Care 1.2%
Rheumatoid Arthritis 1.2%
Cerebrovascular Accident 0.9%
Hypertonia 0.9%
Visual Acuity Reduced 11.3%
Corneal Oedema 7.2%
Ocular Hyperaemia 7.2%
Drug Ineffective 6.2%
Product Quality Issue 6.2%
Toxic Epidermal Necrolysis 6.2%
Anosmia 5.2%
Palpitations 5.2%
Rash 5.2%
Visual Impairment 5.2%
Blindness 4.1%
Somnolence 4.1%
Vision Blurred 4.1%
Weight Decreased 4.1%
Corneal Disorder 3.1%
Eye Injury 3.1%
Eye Irritation 3.1%
Eye Pain 3.1%
Eyelid Margin Crusting 3.1%
Hypertensive Crisis 3.1%
Secondary
Glaucoma 37.7%
Intraocular Pressure Increased 13.6%
Open Angle Glaucoma 9.3%
Normal Tension Glaucoma 7.5%
Venous Occlusion 7.5%
Hypertension 6.3%
Ill-defined Disorder 2.7%
Thyroid Disorder 2.0%
Anaesthesia 1.3%
Developmental Glaucoma 1.3%
Pain In Extremity 1.3%
Product Used For Unknown Indication 1.3%
Hypothyroidism 1.2%
Blood Cholesterol Increased 1.0%
Cerebrovascular Accident Prophylaxis 1.0%
Infection Prophylaxis 1.0%
Keratoconus 1.0%
Ocular Hypertension 1.0%
Osteoporosis 1.0%
Prophylaxis 1.0%
Eye Pain 12.4%
Tinnitus 11.6%
Laceration 9.1%
Visual Acuity Reduced 8.3%
Vitreous Opacities 8.3%
Skin Exfoliation 6.6%
Intraocular Pressure Increased 5.0%
Ocular Hyperaemia 4.1%
Scotoma 4.1%
Vitreous Detachment 4.1%
Intraocular Pressure Fluctuation 3.3%
Raynaud's Phenomenon 3.3%
Conjunctivitis Allergic 2.5%
Diabetic Retinal Oedema 2.5%
Diplopia 2.5%
Drug Rash With Eosinophilia And Systemic Symptoms 2.5%
Ectropion 2.5%
Foreign Body Sensation In Eyes 2.5%
Glaucoma 2.5%
Iritis 2.5%
Concomitant
Glaucoma 23.5%
Drug Use For Unknown Indication 14.7%
Product Used For Unknown Indication 10.6%
Hypertension 9.3%
Breast Cancer 4.4%
Diabetes Mellitus 3.8%
Prophylaxis 3.6%
Pain 3.4%
Multiple Myeloma 3.0%
Type 2 Diabetes Mellitus 2.9%
Juvenile Idiopathic Arthritis 2.8%
Asthma 2.6%
Depression 2.5%
Osteoporosis 2.3%
Arthritis 1.9%
Atrial Fibrillation 1.9%
Non-small Cell Lung Cancer 1.9%
Chronic Obstructive Pulmonary Disease 1.8%
Blood Cholesterol Increased 1.7%
Constipation 1.5%
Intraocular Pressure Increased 13.4%
Visual Acuity Reduced 10.8%
Vomiting 8.2%
Weight Decreased 7.2%
Wheezing 6.2%
Vision Blurred 5.2%
Dyspnoea 4.6%
Hyponatraemia 4.6%
Thrombocytopenia 4.1%
Death 3.6%
Nausea 3.6%
Visual Disturbance 3.6%
Visual Field Defect 3.6%
Fall 3.1%
Malaise 3.1%
Retinal Vein Occlusion 3.1%
Somnolence 3.1%
Stupor 3.1%
Weight Increased 3.1%
Dehydration 2.6%